The cytokine network in chronic obstructive pulmonary disease.
暂无分享,去创建一个
[1] Alvar Agusti,et al. Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.
[2] Parameswaran Nair,et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. , 2009, The New England journal of medicine.
[3] I. Adcock,et al. T helper type 17‐related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients , 2009, Clinical and experimental immunology.
[4] C. Roussos,et al. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease. , 2009, Respiratory medicine.
[5] P. J. Barnes,et al. Systemic manifestations and comorbidities of COPD , 2009, European Respiratory Journal.
[6] V. Kim,et al. Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3. , 2009, American journal of respiratory and critical care medicine.
[7] R. Stockley,et al. Imbalances Between Interleukin-1 and Tumor Necrosis Factor Agonists and Antagonists in Stable COPD , 2009, Journal of Clinical Immunology.
[8] Ana Sousa,et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. , 2009, The New England journal of medicine.
[9] Ashok Kumar,et al. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. , 2009, Inflammation & allergy drug targets.
[10] C. Paige,et al. IL-21: An Executor of B Cell Fate1 , 2009, The Journal of Immunology.
[11] P. Barnes,et al. Role of HDAC2 in the pathophysiology of COPD. , 2009, Annual review of physiology.
[12] J. Phillips,et al. CXCR2 antagonists for the treatment of pulmonary disease. , 2009, Pharmacology & therapeutics.
[13] P. Barnes. Emerging pharmacotherapies for COPD. , 2008, Chest.
[14] P. Barnes,et al. The cytokine network in asthma and chronic obstructive pulmonary disease. , 2008, The Journal of clinical investigation.
[15] C. Dinarello,et al. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.
[16] D. Spina,et al. PDE4 inhibitors: current status , 2008, British journal of pharmacology.
[17] Xiao-Dong Yang,et al. Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. , 2008, DNA and cell biology.
[18] B. O'connor,et al. Expression and Cellular Provenance of Thymic Stromal Lymphopoietin and Chemokines in Patients with Severe Asthma and Chronic Obstructive Pulmonary Disease1 , 2008, The Journal of Immunology.
[19] L. Donnelly,et al. Th17 cells in airway diseases. , 2008, Current molecular medicine.
[20] Rob Leurs,et al. Towards Small‐Molecule CXCR3 Ligands with Clinical Potential , 2008, ChemMedChem.
[21] M. Tsoumakidou,et al. Dendritic cells in chronic obstructive pulmonary disease: new players in an old game. , 2008, American journal of respiratory and critical care medicine.
[22] M. Feldmann,et al. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics , 2008, Immunological reviews.
[23] E. Barillot,et al. A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses , 2008, Nature Immunology.
[24] S. Holgate,et al. Dynamics of pro-inflammatory and anti-inflammatory cytokine release during zcute inflammation in chronic obstructive pulmonary disease: an ex vivo study , 2008, Respiratory research.
[25] D. Littman,et al. The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt , 2008, Nature Immunology.
[26] J. Steinke,et al. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. , 2008, The Journal of allergy and clinical immunology.
[27] J. Clancy,et al. A Novel Proteolytic Cascade Generates an Extracellular Matrix-Derived Chemoattractant in Chronic Neutrophilic Inflammation12 , 2008, The Journal of Immunology.
[28] S. Medicherla,et al. p38α-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation , 2008, Journal of Pharmacology and Experimental Therapeutics.
[29] E. Mercken,et al. Effect of Infliximab on Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease: A Pilot Study , 2008, Respiration.
[30] P. Barnes. Immunology of asthma and chronic obstructive pulmonary disease , 2008, Nature Reviews Immunology.
[31] P. Paré,et al. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. , 2008, American journal of respiratory and critical care medicine.
[32] M. Hudson,et al. TNF-α antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease ☆ , 2008 .
[33] H. Aizawa,et al. Interleukin-18 production and pulmonary function in COPD , 2008, European Respiratory Journal.
[34] L. Fabbri,et al. Increased activation of p38 MAPK in COPD , 2008, European Respiratory Journal.
[35] P. Barnes,et al. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. , 2008, Chest.
[36] J. Curtis,et al. The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. , 2007, Proceedings of the American Thoracic Society.
[37] C. Akdis,et al. TH17 cells in the big picture of immunology. , 2007, The Journal of allergy and clinical immunology.
[38] Lianyu Shan,et al. Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[39] A. D. Panopoulos,et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells , 2007, Nature.
[40] Y. Wan,et al. Regulatory T Cells, Transforming Growth Factor–β, and Immune Suppression , 2007 .
[41] K. Rabe,et al. Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD , 2007, Thorax.
[42] P. Barnes. Unexpected failure of anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[43] S. Rennard,et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[44] B. Pedersen,et al. Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease , 2007, Lung.
[45] Tomoki Ito,et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. , 2007, Annual review of immunology.
[46] June Qin,et al. Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor. , 2007, Blood.
[47] A. Churg,et al. Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. , 2006, American journal of respiratory and critical care medicine.
[48] I. Douglas,et al. Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? , 2006, Proceedings of the American Thoracic Society.
[49] A. Nicholson,et al. Inhibitory effect of p38 mitogen‐activated protein kinase inhibitors on cytokine release from human macrophages , 2006, British journal of pharmacology.
[50] P. Barnes,et al. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. , 2006, Trends in pharmacological sciences.
[51] I. Adcock,et al. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. , 2006, The Journal of allergy and clinical immunology.
[52] A. Kraneveld,et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation , 2006, Nature Medicine.
[53] P. Hiemstra,et al. Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease. , 2006, American journal of clinical pathology.
[54] J. Nadel,et al. Neutrophil Elastase Induces MUC5AC Mucin Production in Human Airway Epithelial Cells via a Cascade Involving Protein Kinase C, Reactive Oxygen Species, and TNF-α-Converting Enzyme1 , 2005, The Journal of Immunology.
[55] P. Hudson,et al. Engineered antibody fragments and the rise of single domains , 2005, Nature Biotechnology.
[56] V. Barbour,et al. Ten Questions about Diabetes Mellitus , 2004 .
[57] P. Barnes. Mediators of Chronic Obstructive Pulmonary Disease , 2004, Pharmacological Reviews.
[58] I. Adcock,et al. Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease , 2004, Histopathology.
[59] Naftali Kaminski,et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[60] Y. Castier,et al. Decreased expression of interleukin 13 in human lung emphysema , 2004, Thorax.
[61] A. Churg,et al. Tumor Necrosis Factor-α Drives 70% of Cigarette Smoke–induced Emphysema in the Mouse , 2004 .
[62] I. Adcock,et al. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease , 2004, European Respiratory Journal.
[63] P. Paré,et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[64] H. Sarau,et al. The FASEB Journal express article 10.1096/fj.03-0170fje. Published online Novermber 3, 2003. Regulation of TNF-α and IFN-γ induced CXCL10 , 2022 .
[65] P. Barnes,et al. High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. , 2003, Respiratory medicine.
[66] R. Atmar,et al. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[67] Y. Ho,et al. Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop* , 2003, The Journal of Biological Chemistry.
[68] K. Hirata,et al. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. , 2003, The American journal of medicine.
[69] P. Shah,et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[70] P. Barnes,et al. Increased levels of the chemokines GROα and MCP-1 in sputum samples from patients with COPD , 2002, Thorax.
[71] P. Barnes,et al. Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[72] L. Fabbri,et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[73] L. Fabbri,et al. Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. , 2001, American journal of respiratory and critical care medicine.
[74] I. Adcock,et al. Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[75] M. Cosio,et al. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. , 2001, The European respiratory journal.
[76] F. Yamasawa,et al. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). , 2001, American journal of respiratory and critical care medicine.
[77] J. Nadel,et al. Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. , 2001, American journal of respiratory and critical care medicine.
[78] K. Wright,et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[79] P. Hirth,et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.
[80] P. Hiemstra,et al. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD , 2000, The Journal of pathology.
[81] T. Seemungal,et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.
[82] P. Hiemstra,et al. Transforming Growth Factor β1 and Recruitment of Macrophages and Mast Cells in Airways in Chronic Obstructive Pulmonary Disease , 1998 .
[83] B. Balbi,et al. Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis. , 1997, The European respiratory journal.
[84] P. Barnes,et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.